The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients.
- 1 October 2008
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 165 (10) , 1227-1228
- https://doi.org/10.1176/appi.ajp.2008.08060957
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2008
- A Comparison of Short- and Long-Term Family Therapy for Adolescent Anorexia NervosaJournal of the American Academy of Child & Adolescent Psychiatry, 2005
- Predictors of Treatment Acceptance and Completion in Anorexia NervosaArchives of General Psychiatry, 2005
- Neurobiology of anorexia nervosa: Clinical implications of alterations of the function of serotonin and other neuronal systemsInternational Journal of Eating Disorders, 2005
- Report of the National Institutes of Health workshop on overcoming barriers to treatment research in anorexia nervosaInternational Journal of Eating Disorders, 2004
- Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [123I]IBZM SPECT studyPsychiatry Research: Neuroimaging, 2001